推荐应用
DNA-binding transcriptional factor that plays a role in a broad range of cellular and developmental processes such as eye, bones, cardiovascular, kidney and skin development. Acts either as a transcriptional activator or repressor. Binds to the consensus binding site 5'-[G/C][A/T]AAA[T/C]AA[A/C]-3' in promoter of target genes. Upon DNA-binding, promotes DNA bending. Acts as a transcriptional coactivator. Stimulates Indian hedgehog (Ihh)-induced target gene expression mediated by the transcription factor GLI2, and hence regulates endochondral ossification . Acts also as a transcriptional coregulator by increasing DNA-binding capacity of GLI2 in breast cancer cells . Regulates FOXO1 through binding to a conserved element, 5'-GTAAACAAA-3' in its promoter region, implicating FOXC1 as an important regulator of cell viability and resistance to oxidative stress in the eye. Cooperates with transcription factor FOXC2 in regulating expression of genes that maintain podocyte integrity . Promotes cell growth inhibition by stopping the cell cycle in the G1 phase through TGFB1-mediated signals. Involved in epithelial-mesenchymal transition (EMT) induction by increasing cell proliferation, migration and invasion. Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression . Plays a role in the gene regulatory network essential for epidermal keratinocyte terminal differentiation. Essential developmental transcriptional factor required for mesoderm-derived tissues, such as the somites, skin, bone and cartilage. Positively regulates CXCL12 and stem cell factor expression in bone marrow mesenchymal progenitor cells, and hence plays a role in the development and maintenance of mesenchymal niches for haematopoietic stem and progenitor cells (HSPC). Plays a role in corneal transparency by preventing both blood vessel and lymphatic vessel growth during embryonic development in a VEGF-dependent manner. Involved in chemokine CXCL12-induced endothelial cell migration through the control of CXCR4 expression . May function as a tumor suppressor.
推荐稀释比 WB:1/500-1/1000;IP:1/20

Western blot analysis of FOXC1 in 3T3 lysates using FOXC1 antibody.
-25 ~ -15℃保存,收到货之后有效期1年,避免反复冻融。
【应用方向】单细胞表观测序中的抗体应用
307
2026-07-29
【选购指南】类器官研究之构建与起始细胞鉴定抗体推荐
686
2026-07-21
【选购指南】类器官研究之功能成熟度评估抗体推荐
517
2026-07-21
【应用方向】趋化因子信号传导通路——身体“信号导航”解析
524
2026-07-21
【选购指南】重度抑郁症(MDD)通路研究抗体推荐
501
2026-07-21
【选购指南】帕金森病(PD)代谢机制核心抗体研究指南
512
2026-07-21
【应用方向】抗体助力心脏免疫研究——解锁心衰防治新方向
454
2026-07-21
【应用方向】抗体助力心肌肥大与心衰研究:从基础探索到科研应用
485
2026-07-21
【应用方向】抗体助力癌症代谢通路研究——肿瘤代谢科普与研究工具指南
533
2026-07-21
【应用方向】心肌再生研究与抗体应用解决方案——助力心血管修复机制解析
13901
2026-03-18
【应用方向】抗体应用研究——心肌纤维化解析
20600
2026-04-14
【技术讲解】抗体赋能心肌梗死研究—精准靶向,助力科研突破
7516
2026-04-14
【应用方向】抗体应用研究—心肌发育的分子解析与前沿转化
15203
2026-04-14
【应用方向】抗体应用研究—细胞死亡
20465
2026-07-16
【应用方向】经典信号通路-JAK/STAT信号转导通路及抗体推荐
13385
2026-04-14





